Dd. Jones et Mk. Cordle, PROSPECTS FOR THE GENETIC MANIPULATION OF DAIRY-CATTLE - OPPORTUNITIES BEYOND BST, Biotechnology advances, 13(2), 1995, pp. 235-246
The dairy industry, with regulatory approvals of recombinant chymosin
and bovine somatotropin (BST), has been at the forefront of food and a
gricultural biotechnology. The commercial fate of these products is on
e of several factors that may affect the success of future genetic man
ipulations in dairy cattle and dairy products. Other factors include t
echnical and reproductive constraints in cattle and the cost of produc
ing transgenic cattle. Early applications of genetic manipulation in c
attle, for reasons of cost recoupment, may favor production of heterol
ogous proteins in mi Ik for pharmaceutical and medical use. Such appli
cations could benefit genetic modification of milk and milk proteins f
or food use by providing advance knowledge and experience in mammalian
protein expression. Other research opportunity areas that could affec
t prospects for genetic manipulation of dairy cattle include genome ma
pping, metabolic pathways, growth and development, and cattle/microbe
interactions.